(Q42487962)

1 November 2017

title

A perspective on the hormonal abnormalities of obesity: are they cause or effect? (English)

1 reference

1 November 2017

0 references

Zumoff B

1

1 reference

1 November 2017

Strain GW

series ordinal

2

1 reference

1 November 2017

language of work or name

1 reference

1 January 1994

1 reference

1 November 2017

1 reference

1 November 2017

volume

2

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

56-67

1 reference

Depressed Plasma Testosterone and Fractional Binding of Testosterone in Obese Males*

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

The Significance of Basal Insulin Levels in the Evaluation of the Insulin Response to Glucose in Diabetic and Nondiabetic Subjects*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

The effects of glucose ingestion and fasting on plasma immunoreactive beta-endorphin, adrenocorticotropic hormone and Cortisol in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Nitrogen Metabolism and Insulin Requirements in Obese Diabetic Adults on a Protein-Sparing Modified Fast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

The influence of diet on the appearance of new lesions in human coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Obesity and insulin resistance in humans: a dose-response study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Effect of obesity and weight loss on arginine vasopressin response to metoclopramide and nicotine from cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Effect of obesity and weight loss on the arginine vasopressin response to insulin-induced hypoglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Gynecologic-obstetric changes after loss of massive excess weight following bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Plasma B-endorphin resistance to dexamethasone suppression in obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Unresponsiveness of the endorphinergic system to its physiological feedback in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Beta-endorphin, insulin, ACTH and cortisol plasma levels during oral glucose tolerance test in obesity after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Endocrine function in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Low serum testosterone and sex-hormone-binding-globulin in massively obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Source of Estrogen Production in Postmenopausal Women1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Insulin and blood pressure in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Evidence for an association of high blood pressure and hyperinsulinemia in obese man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Plasma beta-endorphin levels in obese and non-obese patients with polycystic ovarian disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Naloxone increases the response of growth hormone and prolactin to stimuli in obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Effect of Weight Loss without Salt Restriction on the Reduction of Blood Pressure in Overweight Hypertensive Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Decreased dopaminergic control of prolactin secretion in male obesity: normalization by fasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Hyperendorphinemia in obesity is not related to the affective state

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Plasma beta-endorphin in response to oral glucose tolerance test in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Increased Estrogen Production in Obese Men*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Weight and blood pressure. Findings in hypertension screening of 1 million Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

The effect of weight loss on reproductive hormones in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

The relationship of weight-height indices of obesity to body fat content

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Mild Hypogonadotropic hypogonadism in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Effect of massive weight loss on hypothalamic-pituitary-gonadal function in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Serum-insulin in essential hypertension and in peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

beta-Endorphin and adrenocortical function in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Obese young men have elevated plasma estrogen levels but obese premenopausal women do not

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

Sensitivity to β-endorphin as a cause of human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00045.X

10.1002/J.1550-8528.1994.TB00045.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference